Literature DB >> 7247239

Review of closed capsulotomy complications.

R P Gruber, H W Jones.   

Abstract

Seventy-five closed capsulotomies were reviewed and the degree of capsular contracture graded. The nutcracker technique was employed. In 35 cases, tonometric measurements before and after capsulotomy quantitated the improvement. Complications included inability to rupture the capsule, recurrence of contracture, distortion of breast shape, and in 1 patient, implant rupture. The degree of breast softness after capsulotomy correlated well with tonometry and was inversely proportional to the degree of preexisting capsular contracture. Softness was also proportional to the latency of onset of contracture. Analysis of the results suggests that capsulotomy is best performed in the patient with mild to moderate contracture and is containdicated in patients with severe contracture or breast distortion from previous capsulotomy. The nutcracker technique is advised, and reduction of pressure is urged once the capsular tear is heard. Closed capsulotomy usually, but not always improves breast firmness. It provides the physician with a nonoperative means of coping with an undesirable result.

Entities:  

Mesh:

Year:  1981        PMID: 7247239     DOI: 10.1097/00000637-198104000-00003

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  2 in total

1.  Ultrasound-guided percutaneous injection of triamcinolone acetonide for treating capsular contracture in patients with augmented and reconstructed breast.

Authors:  Luca Maria Sconfienza; Carmelina Murolo; Simone Callegari; Massimo Calabrese; Edoardo Savarino; Pierluigi Santi; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2010-08-09       Impact factor: 5.315

2.  Nonsurgical treatment of capsular contracture: Review of clinical studies.

Authors:  Anthony Papaconstantinou; Triantafyllia Koletsa; Efterpi Demiri; Kostantinos Gasteratos; Sofia-Eleni Tzorakoleftheraki; Leonidas Pavlidis; Georgia-Alexandra Spyropoulou
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.